GVK Biosciences has acquired balance 987,500 equity shares constituting 6.12% of voting powers of Inogent Laboratories from Dai-Ichi Karkaria on July 11, 2014, at a consideration aggregating to Rs 8.97 crore.
GVK Biosciences has acquired the shares pursuant to the call option under the joint venture and shareholders agreement among GVK Biosciences, Dai-Ichi Karkaria and Inogent Laboratories, dated October 14, 2005.
Accordingly, the shareholding of the company in Inogent Laboratories after acquisition by GVK Biosciences will be nil and the agreement shall be treated as concluded.
| Company Name | CMP |
|---|---|
| BASF India | 3668.45 |
| Tata Chemicals | 719.90 |
| SRF | 2498.45 |
| Pidilite Inds. | 1329.15 |
| Deepak Nitrite | 1520.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: